As you may know, Medicare Part D prescription drug plans update their plan formularies (drug lists) throughout the plan year and the April 2021
Medicare Part D formulary updates included 95 new drugs, 55 of which are new generic drugs - with a total of 84 new generic equivalents
(variations of manufacturer, drug-strength, and packaging).
Below is a full list of the new generics added to the 2021 Medicare Part D (PDP) and Medicare Advantage plan (MAPD) formularies:
Below is a full list of the new generics added to the 2021 Medicare Part D (PDP) and Medicare Advantage plan (MAPD) formularies:
|
|
Number of |
Number of |
| ACARBOSE 100 MG TABLET [Precose] | 68 | 400 |
| ACARBOSE 25 MG TABLET [Precose] | 68 | 400 |
| ACARBOSE 50 MG TABLET [Precose] | 68 | 400 |
| ALA-CORT 2.5% CREAM (G) [Proctozone-HC] | 50 | 275 |
| AMABELZ 0.5 MG-0.1 MG TABLET [Mimvey Lo] | 32 | 304 |
| AMABELZ 1 MG-0.5 MG TABLET [Mimvey] | 43 | 318 |
| ASENAPINE 10 MG SUBLIGUAL TABLET [Saphris] | 65 | 385 |
| ASENAPINE 2.5 MG SUBLIGUAL TABLET [Saphris] | 65 | 385 |
| ASENAPINE 5 MG SUBLIGUAL TABLET [Saphris] | 65 | 385 |
| BETAMETHASONE DP AUG 0.05% OINTMENT [Diprolene] | 59 | 384 |
| CALCIPOTRIENE 0.005% OINTMENT [Dovonex] | 49 | 336 |
| CASPOFUNGIN ACETATE 50 MG VIAL [Cancidas] | 64 | 374 |
| CASPOFUNGIN ACETATE 70 MG VIAL [Cancidas] | 64 | 374 |
| CEFACLOR 250 MG CAPSULE [Ceclor] | 67 | 395 |
| CEFACLOR 500 MG CAPSULE [Ceclor] | 68 | 395 |
| CEFADROXIL 1 GM TABLET [Duricef] | 39 | 280 |
| CHLORDIAZEPOXIDE-CLIDINIUM CAPSULE [Librax] | 0 | 14 |
| DAPTOMYCIN 350 MG VIAL [Cubicin RF] | 37 | 237 |
| DICLOFENAC SODIUM 1% GEL [Voltaren Gel] | 68 | 400 |
| DILTIAZEM 24H ER(LA) 180 MG TABLET [Matzim LA] | 37 | 235 |
| DILTIAZEM 24H ER(LA) 240 MG TABLET [Matzim LA] | 37 | 235 |
| DILTIAZEM 24H ER(LA) 300 MG TABLET [Matzim LA] | 37 | 235 |
| DILTIAZEM 24H ER(LA) 360 MG TABLET [Matzim LA] | 37 | 235 |
| DIMETHYL FUMARATE 30D START PK CAPSULE DR [Tecfidera] | 40 | 274 |
| DOXEPIN HCL 3 MG TABLET [Silenor] | 36 | 222 |
| DOXEPIN HCL 6 MG TABLET [Silenor] | 36 | 222 |
| FLUOCINONIDE 0.05% CREAM (G) [Lidex] | 57 | 368 |
| FYAVOLV 0.5 MG-2.5 MCG TABLET [Jevantique] | 29 | 297 |
| FYAVOLV 1 MG-5 MCG TABLET [Jinteli 1/5] | 29 | 300 |
| GLYBURIDE MICRO 1.5 MG TABLET [Glynase PresTab] | 37 | 232 |
| GLYBURIDE MICRO 6 MG TABLET [Glynase PresTab] | 37 | 232 |
| HYDROCODONE-IBUPROFEN 10-200 TABLET [Xylon 10] | 17 | 239 |
| HYDROCODONE-IBUPROFEN 5-200 MG TABLET [Reprexain] | 17 | 243 |
| HYDROCODONE-IBUPROFEN 7.5-200 TABLET [Vicoprofen] | 51 | 360 |
| HYDROMORPHONE 1 MG/ML SOLUTION LIQUID [Dilaudid] | 57 | 343 |
| ICLEVIA 0.15 MG-0.03 MG TABLET TBDSPK 3MO [Setlakin] | 56 | 322 |
| ICLUSIG 10 MG TABLET | 68 | 399 |
| ICLUSIG 30 MG TABLET | 68 | 399 |
| ICOSAPENT ETHYL 1 GRAM CAPSULE [VASCEPA] | 41 | 182 |
| IVERMECTIN 0.5% LOTION [Sklice] | 2 | 83 |
| LANSOPRAZOLE DR 30 MG CAPSULE DR [Prevacid] | 47 | 386 |
| LEVOTHYROXINE 100 MCG CAPSULE [Tirosint] | 1 | 30 |
| LEVOTHYROXINE 112 MCG CAPSULE [Tirosint] | 1 | 30 |
| LEVOTHYROXINE 125 MCG CAPSULE [Tirosint] | 1 | 30 |
| LEVOTHYROXINE 13 MCG CAPSULE [Tirosint] | 1 | 31 |
| LEVOTHYROXINE 137 MCG CAPSULE [Tirosint] | 1 | 30 |
| LEVOTHYROXINE 150 MCG CAPSULE [Tirosint] | 1 | 30 |
| LEVOTHYROXINE 175 MCG CAPSULE [Tirosint] | 1 | 30 |
| LEVOTHYROXINE 200 MCG CAPSULE [Tirosint] | 1 | 30 |
| LEVOTHYROXINE 25 MCG CAPSULE [Tirosint] | 1 | 30 |
| LEVOTHYROXINE 50 MCG CAPSULE [Tirosint] | 1 | 30 |
| LEVOTHYROXINE 75 MCG CAPSULE [Tirosint] | 1 | 30 |
| LEVOTHYROXINE 88 MCG CAPSULE [Tirosint] | 1 | 30 |
| LYLEQ 0.35 MG TABLET [Sharobel 28-Day] | 59 | 337 |
| MERZEE 1 MG-20 MCG CAPSULE [Taytulla] | 13 | 107 |
| METHADONE HCL 5 MG TABLET [Methadose] | 68 | 390 |
| METHOXSALEN 10 MG SOFTGEL CAP LQ RAP | 37 | 296 |
| METRONIDAZOLE 0.75% CREAM (G) [Vitazol] | 68 | 399 |
| NAPROXEN 125 MG/5 ML ORAL SUSPENSION [Naprosyn] | 37 | 172 |
| NAPROXEN DR 375 MG TABLET DR [EC-Naprosyn] | 57 | 381 |
| NAPROXEN DR 500 MG TABLET DR [EC-Naprosyn] | 57 | 381 |
| NISOLDIPINE ER 17 MG TABLET ER 24H [Sular] | 24 | 213 |
| NISOLDIPINE ER 34 MG TABLET ER 24H [Sular] | 24 | 213 |
| NISOLDIPINE ER 8.5 MG TABLET ER 24H [Sular] | 24 | 213 |
| NITAZOXANIDE 500 MG TABLET [Alinia] | 67 | 396 |
| NITROFURANTOIN 25 MG/5 ML ORAL SUSPENSION [Furadantin] | 34 | 149 |
| NYLIA 7-7-7-28 TABLET [Pirmella] | 56 | 343 |
| OFLOXACIN 300 MG TABLET [Floxin] | 15 | 160 |
| OFLOXACIN 400 MG TABLET [Floxin] | 28 | 255 |
| OXYCODONE-ACETAMINOPHEN 5-325 TABLET [Roxicet] | 68 | 400 |
| PANTOPRAZOLE SOD DR 40 MG TABLET DR [Protonix] | 68 | 400 |
| POTASSIUM CL 20 MEQ PACKET [Klor-Con] | 28 | 257 |
| RUFINAMIDE 40 MG/ML ORAL SUSPENSION [Banzel] | 68 | 394 |
| SAPROPTERIN 100 MG TABLET SOL [KUVAN] | 68 | 393 |
| SODIUM CHLORIDE 0.45% SOLUTION IV SOLUTION | 67 | 360 |
| THEOPHYLLINE ER 400 MG TABLET ER 24H [Uniphyl] | 68 | 399 |
| THEOPHYLLINE ER 600 MG TABLET ER 24H [Uniphyl] | 68 | 399 |
| TIAGABINE HCL 2 MG TABLET [Gabitril] | 68 | 400 |
| TILIA FE 28 TABLET [Tri-Legest Fe] | 51 | 272 |
| TIMOLOL 0.25% GEL-SOLUTION SOL-GEL [Timoptic-XE] | 68 | 387 |
| TIMOLOL 0.5% GEL-SOLUTION SOL-GEL [Timoptic-XE] | 68 | 387 |
| VENLAFAXINE HCL 100 MG TABLET [Effexor] | 68 | 400 |
| VYFEMLA 0.4 MG-0.035 MG TABLET [Zenchent] | 59 | 350 |
| ZAFIRLUKAST 20 MG TABLET [Accolate] | 68 | 397 |
*The number of formularies counts the unique formularies that offer this
medication. As a note, the same formulary can be used by one or many
different Medicare Part D plans. The same formulary can be used by both
PDP and MAPD plans.
What Could the Addition of New Generic Drugs Mean to You?
- You may be able to save money by switching
from the brand-name drug to its generic equivalent – with your prescriber’s
approval and a new prescription. Please note, you will need to look
carefully at coverage costs as we have found that many 2021 generics are being
offered on the same tier as their brand-name equivalent or the generics do not
have a significantly lower retail price.
- Your brand-name drug may no longer be
available if a generic is now available. Based on past
experience, you may find that many Medicare Part D plans discontinue
coverage for the brand-name drug in the months following the
introduction of the generic equivalent - or your plan may immediately drop the brand-name drug now that the generic is being introduced
.
If you have received notice from your Medicare Part D plan that your brand-name medication will be dropped, you should speak with your prescriber to determine if you can take the generic equivalent or if you must continue taking the brand-name drug, you will need to ask your plan for a formulary exception to continue coverage for your brand-name drug.
You can click for a chart showing the trends in formulary coverage for some of the more popular Medicare drugs and their generic equivalents.
Additional Formulary Drug Change Articles:
Medicare Part D Plan Formulary (Drug Lists) Updates:
June 2026, May 2026, March-April 2026, February 2026, 2026 Rx: November 2025, August 2025, July 2025, June 2025, April 2025, March 2025, June 2024, May 2024, April 2024, September 2023, August 2023, June 2023, May 2023, April 2023, March 2023, February 2023, August 2022, June 2022, May 2022, April 2022, March 2022, February 2022, August 2021, June 2021, May 2021, April 2021, September 2020, August 2020, June 2020, May 2020, April 2020, March 2020, September 2019, July 2019, June 2019, May 2019, April 2019, March 2019, August 2018, July 2018, June 2018, May 2018, April 2018, August 2017, July 2017, May 2017, April 2017, August 2016, July 2016, June 2016, April 2016, March 2016, October 2015, August 2015, July 2015, May 2015, April 2015, August 2014, May 2014, August 2013, June 2013, May 2013, April 2013, August 2012, July 2012, June 2012
New Generic Equivalents Added to Formularies:
2026 Gnrcs: November 2025 May 2024, June 2023, February 2023, August 2021, June 2021, May 2021, April 2021, September 2020, August 2020, June 2020, May 2020, April 2020, March 2020, September 2019, July 2019, June 2019, May 2019, April 2019, March 2019, August 2018, July 2018, April 2018, August 2017, July 2017, April 2017, March & April 2016, April & May 2015, August 2014, May 2014
Medicare Part D Plan Formulary (Drug Lists) Updates:
June 2026, May 2026, March-April 2026, February 2026, 2026 Rx: November 2025, August 2025, July 2025, June 2025, April 2025, March 2025, June 2024, May 2024, April 2024, September 2023, August 2023, June 2023, May 2023, April 2023, March 2023, February 2023, August 2022, June 2022, May 2022, April 2022, March 2022, February 2022, August 2021, June 2021, May 2021, April 2021, September 2020, August 2020, June 2020, May 2020, April 2020, March 2020, September 2019, July 2019, June 2019, May 2019, April 2019, March 2019, August 2018, July 2018, June 2018, May 2018, April 2018, August 2017, July 2017, May 2017, April 2017, August 2016, July 2016, June 2016, April 2016, March 2016, October 2015, August 2015, July 2015, May 2015, April 2015, August 2014, May 2014, August 2013, June 2013, May 2013, April 2013, August 2012, July 2012, June 2012
New Generic Equivalents Added to Formularies:
2026 Gnrcs: November 2025 May 2024, June 2023, February 2023, August 2021, June 2021, May 2021, April 2021, September 2020, August 2020, June 2020, May 2020, April 2020, March 2020, September 2019, July 2019, June 2019, May 2019, April 2019, March 2019, August 2018, July 2018, April 2018, August 2017, July 2017, April 2017, March & April 2016, April & May 2015, August 2014, May 2014
- Browse Medicare Part D prescription drug plans
- Browse Medicare Advantage plans (MAPD)
- Sign-up for our Medicare Part D Newsletter
- Have a question? Click here to let us know